Grey Wolf Animal Health (TSXV:WOLF) Research & Development: C$0.00 Mil (TTM As of Mar. 2026)


TSXV:WOLF Grey Wolf Animal Health Corp TSXV:WOLF
57 GF Score
Price C$1.79
GF Value C$1.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Animal Health Research & Development?

Grey Wolf Animal Health TSXV:WOLF 57 Research & Development is C$0.00 Mil as of Mar. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 57/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Grey Wolf Animal Health's Research & Development for the three months ended in Mar. 2026 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.00 Mil.

Grey Wolf Animal Health  (TSXV:WOLF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Grey Wolf Animal Health Research & Development Related Terms

Grey Wolf Animal Health Research & Development Historical Data

* Premium members only.

The historical data trend for Grey Wolf Animal Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Animal Health Research & Development Chart

Grey Wolf Animal Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.05 0.06 0.07 0.10 0.15

Grey Wolf Animal Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSXV:WOLF
57GF Score
Grey Wolf Animal Health Corp TSXV:WOLF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Wolf Animal Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.00 Mil mean?
Grey Wolf Animal Health (TSXV:WOLF) has a Research & Development of C$0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Grey Wolf Animal Health and its competitors.
Is Grey Wolf Animal Health's Research & Development too high?
Grey Wolf Animal Health's current Research & Development is C$0.00 Mil. Overall, Grey Wolf Animal Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Animal Health's Research & Development compare to ROL and SCI?
Grey Wolf Animal Health's Research & Development of C$0.00 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Personal Services company?
A good Research & Development depends on the Personal Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Grey Wolf Animal Health and its competitors. Grey Wolf Animal Health's current Research & Development is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Animal Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.79 — trading 62.7% above its estimated fair value. The current Research & Development is C$0.00 Mil. Grey Wolf Animal Health's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Grey Wolf Animal Health (TSXV:WOLF), the current Research & Development is C$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Animal Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Animal Health stock appears to be overvalued. The current stock price of C$1.79 is trading 62.7% above its estimated GF Value™ of C$1.10. GuruFocus considers Grey Wolf Animal Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • Research & Development: C$0.00 Mil
  • GF Value™: C$1.10 vs. price of C$1.79 (62.7% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grey Wolf Animal Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
57GF Score

Get the complete analysis for TSXV:WOLF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.79
Price
C$1.10
GF Value